Viet Nam Pharmaceutical Corp - JSC stock PB Ratio (=1.23) is close to 5-year low of 1.23.
The historical rank and industry rank for Viet Nam Pharmaceutical - JSC's PB Ratio or its related term are showing as below:
HSTC:DVN'
s PB Ratio Range Over the Past 10 Years
Min: 0.82 Med: 1.55 Max: 2.57
Current: 1.21
During the past 7 years, Viet Nam Pharmaceutical - JSC's highest PB Ratio was 2.57. The lowest was 0.82. And the median was 1.55.
HSTC:DVN's PB Ratio is ranked better than 68.34% of 919
companies
in the Drug Manufacturers industry
Industry Median: 1.91
vs HSTC:DVN: 1.21
During the past 12 months, Viet Nam Pharmaceutical - JSC's average Book Value Per Share Growth Rate was 16.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 13.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.20% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Viet Nam Pharmaceutical - JSC was 13.00% per year. The lowest was -0.80% per year. And the median was 3.90% per year.
Back to Basics: PB Ratio
Viet Nam Pharmaceutical - JSC (HSTC:DVN) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Viet Nam Pharmaceutical - JSC PB Ratio Related Terms
Viet Nam Pharmaceutical - JSC PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Viet Nam Pharmaceutical - JSC's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viet Nam Pharmaceutical - JSC PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Viet Nam Pharmaceutical - JSC's PB Ratio distribution charts can be found below:
* The bar in red indicates where Viet Nam Pharmaceutical - JSC's PB Ratio falls into.
Viet Nam Pharmaceutical - JSC PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Viet Nam Pharmaceutical - JSC (HSTC:DVN) has a PB Ratio of 1.22 as of Jul. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Viet Nam Pharmaceutical - JSC and its competitors. This is 21% below median its historical median of 1.55. Over the past decade, Viet Nam Pharmaceutical - JSC's PB Ratio has ranged from 0.82 to 2.57. According to the industry distribution chart, Viet Nam Pharmaceutical - JSC ranks #291 out of 919 companies in the Drug Manufacturers industry, placing it in the top 31.7%.
Is Viet Nam Pharmaceutical - JSC's PB Ratio too high?
Viet Nam Pharmaceutical - JSC's current PB Ratio of 1.22 is 21% below median its 10-year median of 1.55. Over the past 10 years, this metric has ranged from a low of 0.82 to a high of 2.57. The Drug Manufacturers industry median PB Ratio is 1.91. Viet Nam Pharmaceutical - JSC's value of 1.22 is 36.1% below this industry median. Based on the distribution chart, Viet Nam Pharmaceutical - JSC ranks #291 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Viet Nam Pharmaceutical - JSC has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Viet Nam Pharmaceutical - JSC's PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Viet Nam Pharmaceutical - JSC ranks #291 out of 919 companies for PB Ratio. This puts Viet Nam Pharmaceutical - JSC in the upper half of its industry. The industry median PB Ratio is 1.91. Viet Nam Pharmaceutical - JSC's value of 1.22 is 36.1% below this benchmark. Historically, Viet Nam Pharmaceutical - JSC's own PB Ratio has ranged from 0.82 to 2.57 over the past decade. While the company's 10-year median is 1.55 vs. the industry median of 1.91, Viet Nam Pharmaceutical - JSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.91, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viet Nam Pharmaceutical - JSC's current PB Ratio of 1.22 is 36.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Viet Nam Pharmaceutical - JSC and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viet Nam Pharmaceutical - JSC's current PB Ratio is 1.22, which is 21% below median its own 10-year median of 1.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viet Nam Pharmaceutical - JSC stock overvalued right now?
Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC (HSTC:DVN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫22,074.26, compared to a current price of ₫19,900.00 — trading 9.8% below its estimated fair value. The current PB Ratio is 1.22, which is 21% below median its 10-year median of 1.55 and 36.1% below the Drug Manufacturers industry median of 1.91. Viet Nam Pharmaceutical - JSC's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Viet Nam Pharmaceutical - JSC (HSTC:DVN), the current PB Ratio is 1.22 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viet Nam Pharmaceutical - JSC (HSTC:DVN) Overvalued in 2026?
Based on GuruFocus' analysis, Viet Nam Pharmaceutical - JSC stock appears to be undervalued.
The current stock price of ₫19,900.00 is trading 9.8% below its estimated GF Value™ of ₫22,074.26.
GuruFocus considers Viet Nam Pharmaceutical - JSC to be Modestly Undervalued.
Key valuation signals for HSTC:DVN:
PB Ratio: 1.22 (21% below median its 10-year median of 1.55)
GF Value™: ₫22,074.26 vs. price of ₫19,900.00 (9.8% below fair value)
Industry Position: 36.1% below the Drug Manufacturers median (#291 of 919)
No single metric tells the full story. See the HSTC:DVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viet Nam Pharmaceutical - JSC Business Description
Viet Nam Pharmaceutical Corp - JSC is engaged in the manufacturing of drugs. The company provides testing services for drugs and medicinal ingredients.
79GF Score
Get the complete analysis for HSTC:DVN
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:DVN has been successfully added to your 
